Vista do Castration-resistant prostate cancer: current status of therapy with Radium-223 associated with anti-androgens (enzalutamide and abiraterone) - a systematic literature review

Voltar aos Detalhes do Artigo Castration-resistant prostate cancer: current status of therapy with Radium-223 associated with anti-androgens (enzalutamide and abiraterone) - a systematic literature review Baixar Baixar PDF